{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T11:17:53Z","timestamp":1791371873355,"version":"4.3.1"},"reference-count":28,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":973,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2013,1]]},"abstract":"<jats:sec>\n            <jats:title>Abstract<\/jats:title>\n            <jats:p>The majority of patients with nonalcoholic fatty liver disease (NAFLD) have \u201csimple steatosis,\u201d which is defined by hepatic steatosis in the absence of substantial inflammation or fibrosis and is considered to be benign. However, 10%-30% of patients with NAFLD progress to fibrosing nonalcoholic steatohepatitis (NASH), which is characterized by varying degrees of hepatic inflammation and fibrosis, in addition to hepatic steatosis, and can lead to cirrhosis. The cause(s) of progression to fibrosing steatohepatitis are unclear. We aimed to test the relative contributions of dietary fat and dietary cholesterol and their interaction on the development of NASH. We assigned C57BL\/6J mice to four diets for 30 weeks: control (4% fat and 0% cholesterol); high cholesterol (HC; 4% fat and 1% cholesterol); high fat (HF; 15% fat and 0% cholesterol); and high fat, high cholesterol (HFHC; 15% fat and 1% cholesterol). The HF and HC diets led to increased hepatic fat deposition with little inflammation and no fibrosis (i.e., simple hepatic steatosis). However, the HFHC diet led to significantly more profound hepatic steatosis, substantial inflammation, and perisinusoidal fibrosis (i.e., steatohepatitis), associated with adipose tissue inflammation and a reduction in plasma adiponectin levels. In addition, the HFHC diet led to other features of human NASH, including hypercholesterolemia and obesity. Hepatic and metabolic effects induced by dietary fat and cholesterol together were more than twice as great as the sum of the separate effects of each dietary component alone, demonstrating significant positive interaction. <jats:italic toggle=\"yes\">Conclusion:<\/jats:italic> Dietary fat and dietary cholesterol interact synergistically to induce the metabolic and hepatic features of NASH, whereas neither factor alone is sufficient to cause NASH in mice. (Hepatology 2013)<\/jats:p>\n          <\/jats:sec>","DOI":"10.1002\/hep.25789","type":"journal-article","created":{"date-parts":[[2012,4,16]],"date-time":"2012-04-16T13:01:40Z","timestamp":1334581300000},"page":"81-92","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":276,"title":["Synergistic interaction of dietary cholesterol and dietary fat in inducing experimental steatohepatitis"],"prefix":"10.1097","volume":"57","author":[{"given":"Christopher","family":"Savard","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erica V.","family":"Tartaglione","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rahul","family":"Kuver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geoffrey W.","family":"Haigh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geoffrey C.","family":"Farrell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Savitha","family":"Subramanian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan","family":"Chait","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew M.","family":"Yeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"LeBris S.","family":"Quinn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George N.","family":"Ioannou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-11-20241201","doi-asserted-by":"crossref","first-page":"13871395","DOI":"10.1002\/hep.20466","article-title":"Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity.","volume":"40","author":"Browning","year":"2004","journal-title":"HEPATOLOGY"},{"key":"R2-11-20241201","doi-asserted-by":"crossref","first-page":"124131","DOI":"10.1053\/j.gastro.2010.09.038","article-title":"Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middleaged population utilizing ultrasound and liver biopsy: a prospective study.","volume":"140","author":"Williams","year":"2011","journal-title":"Gastroenterology"},{"key":"R3-11-20241201","doi-asserted-by":"crossref","first-page":"14131419","DOI":"10.1016\/S0016-5085(99)70506-8","article-title":"Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity.","volume":"116","author":"Matteoni","year":"1999","journal-title":"Gastroenterology"},{"key":"R4-11-20241201","doi-asserted-by":"crossref","first-page":"134140","DOI":"10.1053\/gast.2002.34168","article-title":"Expanding the natural history of nonalcoholic steatohepatitis: from cryptogenic cirrhosis to hepatocellular carcinoma.","volume":"123","author":"Bugianesi","year":"2002","journal-title":"Gastroenterology"},{"key":"R5-11-20241201","doi-asserted-by":"crossref","first-page":"13921403","DOI":"10.1002\/hep.21874","article-title":"Lipidinduced oxidative stress causes steatohepatitis in mice fed an atherogenic diet.","volume":"46","author":"Matsuzawa","year":"2007","journal-title":"HEPATOLOGY"},{"key":"R7-11-20241201","doi-asserted-by":"crossref","first-page":"16261635","DOI":"10.1194\/jlr.M016246","article-title":"Dietary cholesterol exacerbates hepatic steatosis and inflammation in obese LDL receptordeficient mice.","volume":"52","author":"Subramanian","year":"2011","journal-title":"J Lipid Res"},{"key":"R9-11-20241201","doi-asserted-by":"crossref","first-page":"175184","DOI":"10.1002\/hep.22941","article-title":"Association between dietary nutrient composition and the incidence of cirrhosis or liver cancer in the United States population.","volume":"50","author":"Ioannou","year":"2009","journal-title":"HEPATOLOGY"},{"key":"R10-11-20241201","doi-asserted-by":"crossref","first-page":"613621","DOI":"10.1111\/j.1872-034X.2010.00644.x","article-title":"Efficacy of ezetimibe for the treatment of nonalcoholic steatohepatitis: an openlabel, pilot study.","volume":"40","author":"Yoneda","year":"2010","journal-title":"Hepatol Res"},{"key":"R11-11-20241201","doi-asserted-by":"crossref","first-page":"101107","DOI":"10.1007\/s00535-010-0291-8","article-title":"Efficacy of longterm ezetimibe therapy in patients with nonalcoholic fatty liver disease.","volume":"46","author":"Park","year":"2011","journal-title":"J Gastroenterol"},{"key":"R12-11-20241201","doi-asserted-by":"crossref","first-page":"13131321","DOI":"10.1002\/hep.20701","article-title":"Design and validation of a histological scoring system for nonalcoholic fatty liver disease.","volume":"41","author":"Kleiner","year":"2005","journal-title":"HEPATOLOGY"},{"key":"R13-11-20241201","doi-asserted-by":"crossref","first-page":"497509","DOI":"10.1016\/S0021-9258(18)64849-5","article-title":"A simple method for the isolation and purification of total lipides from animal tissues.","volume":"226","author":"Folch","year":"1957","journal-title":"J Biol Chem"},{"key":"R14-11-20241201","doi-asserted-by":"crossref","first-page":"957969","DOI":"10.1002\/hep.23046","article-title":"Adipokines in liver diseases.","volume":"50","author":"Marra","year":"2009","journal-title":"HEPATOLOGY"},{"key":"R15-11-20241201","doi-asserted-by":"crossref","first-page":"26212637","DOI":"10.1172\/JCI31021","article-title":"Obesityassociated improvements in metabolic profile through expansion of adipose tissue.","volume":"117","author":"Kim","year":"2007","journal-title":"J Clin Invest"},{"key":"R16-11-20241201","doi-asserted-by":"crossref","first-page":"772783","DOI":"10.1038\/nri1937","article-title":"Adipocytokines: mediators linking adipose tissue, inflammation, and immunity.","volume":"6","author":"Tilg","year":"2006","journal-title":"Nat Rev Immunol"},{"key":"R17-11-20241201","doi-asserted-by":"crossref","first-page":"140149","DOI":"10.1016\/j.jhep.2008.08.023","article-title":"Adiponectin inhibits steatotic CD95Fas upregulation by hepatocytes: therapeutic implications for hepatitis C.","volume":"50","author":"Wedemeyer","year":"2009","journal-title":"J Hepatol"},{"key":"R18-11-20241201","doi-asserted-by":"crossref","first-page":"677685","DOI":"10.1002\/hep.21991","article-title":"High molecular weight adiponectin inhibits proliferation of hepatic stellate cells via activation of adenosine monophosphateactivated protein kinase.","volume":"47","author":"Adachi","year":"2008","journal-title":"HEPATOLOGY"},{"key":"R19-11-20241201","doi-asserted-by":"crossref","first-page":"905911","DOI":"10.1172\/JCI0216452","article-title":"Consequences of cellular cholesterol accumulation: basic concepts and physiological implications.","volume":"110","author":"Tabas","year":"2002","journal-title":"J Clin Invest"},{"key":"R20-11-20241201","doi-asserted-by":"crossref","first-page":"185198","DOI":"10.1016\/j.cmet.2006.07.006","article-title":"Mitochondrial free cholesterol loading sensitizes to TNF and Fasmediated steatohepatitis.","volume":"4","author":"Mari","year":"2006","journal-title":"Cell Metab"},{"key":"R21-11-20241201","doi-asserted-by":"crossref","first-page":"781792","DOI":"10.1038\/ncb1035","article-title":"The endoplasmic reticulum is the site of cholesterolinduced cytotoxicity in macrophages.","volume":"5","author":"Feng","year":"2003","journal-title":"Nat Cell Biol"},{"key":"R22-11-20241201","doi-asserted-by":"crossref","first-page":"855864","DOI":"10.1002\/hep.510240417","article-title":"Hepatic sinusoidal fibrosis induced by cholesterol and stilbestrol in the rabbit: 1. Morphology and inhibition of fibrogenesis by dipyridamole.","volume":"24","author":"Wanless","year":"1996","journal-title":"HEPATOLOGY"},{"key":"R23-11-20241201","doi-asserted-by":"crossref","first-page":"18361846","DOI":"10.1002\/hep.24001","article-title":"Evolution of inflammation in nonalcoholic fatty liver disease: the multiple parallel hits hypothesis.","volume":"52","author":"Tilg","year":"2010","journal-title":"HEPATOLOGY"},{"key":"R24-11-20241201","doi-asserted-by":"crossref","first-page":"G852G858","DOI":"10.1152\/ajpgi.00521.2005","article-title":"Lipid metabolism and liver inflammation. II. Fatty liver disease and fatty acid oxidation.","volume":"290","author":"Reddy","year":"2006","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"R25-11-20241201","doi-asserted-by":"crossref","first-page":"13661374","DOI":"10.1002\/hep.21655","article-title":"Inhibiting triglyceride synthesis improves hepatic steatosis but exacerbates liver damage and fibrosis in obese mice with nonalcoholic steatohepatitis.","volume":"45","author":"Yamaguchi","year":"2007","journal-title":"HEPATOLOGY"},{"key":"R26-11-20241201","doi-asserted-by":"crossref","first-page":"1638116385","DOI":"10.1073\/pnas.1113359108","article-title":"Cellular mechanism of insulin resistance in nonalcoholic fatty liver disease.","volume":"108","author":"Kumashiro","year":"2011","journal-title":"Proc Natl Acad Sci USA"},{"key":"R27-11-20241201","doi-asserted-by":"crossref","first-page":"G776G783","DOI":"10.1152\/ajpgi.90275.2008","article-title":"Reduced absorption of saturated fatty acids and resistance to dietinduced obesity and diabetes by ezetimibetreated and Npc1l1 mice.","volume":"295","author":"Labonte","year":"2008","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"R28-11-20241201","doi-asserted-by":"crossref","first-page":"31353144","DOI":"10.1194\/jlr.M006353","article-title":"NiemannPick C1Like 1 deletion in mice prevents highfat dietinduced fatty liver by reducing lipogenesis.","volume":"51","author":"Jia","year":"2010","journal-title":"J Lipid Res"},{"key":"R29-11-20241201","doi-asserted-by":"crossref","first-page":"1271012720","DOI":"10.1074\/jbc.M409110200","article-title":"Inactivation of NPC1L1 causes multiple lipid transport defects and protects against dietinduced hypercholesterolemia.","volume":"280","author":"Davies","year":"2005","journal-title":"J Biol Chem"},{"key":"R30-11-20241201","doi-asserted-by":"crossref","first-page":"4277442784","DOI":"10.1074\/jbc.M306022200","article-title":"Cholesterol and cholate components of an atherogenic diet induce distinct stages of hepatic inflammatory gene expression.","volume":"278","author":"Vergnes","year":"2003","journal-title":"J Biol Chem"}],"container-title":["Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fhep.25789","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.lww.com\/01515467-201301000-00011","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T14:03:13Z","timestamp":1733061793000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/01515467-201301000-00011"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1002\/hep.25789","relation":{},"ISSN":["0270-9139"],"issn-type":[{"value":"0270-9139","type":"print"}],"subject":[],"published":{"date-parts":[[2013,1]]}}}